Financial Sense Advisors, Inc. Gilead Sciences, Inc. Transaction History

Financial Sense Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 21, 2020	SELL	$62.1 - $78.08 $186,300 - $234,240	-3,000 Closed	0 $0
Q1 2020 Apr 20, 2020	BUY	$62.63 - $80.22 $187,890 - $240,660	3,000 New	3,000 $224,000
Q3 2019 Nov 08, 2019	SELL	$62.51 - $69.0 $187,530 - $207,000	-3,000 Closed	0 $0
Q2 2019 Aug 02, 2019	BUY	$61.87 - $69.38 $185,610 - $208,140	3,000 New	3,000 $203,000
Q4 2017 Feb 09, 2018	SELL	$71.15 - $83.52 $427,611 - $501,955	-6,010 Closed	0 $0
Q3 2017 Oct 24, 2017	BUY	$72.11 - $85.47 $433,381 - $513,674	6,010	6,010 $487,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Financial Sense Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Sense Advisors, Inc. with notifications on news.